Exit Notice
You are about to leave ClinicalTrials.gov and go to: Dose Escalation Study of JNJ-64007957, a Humanized BCMA CD3 DuoBody® Antibody, in Participants With Relapsed or Refractory Multiple Myeloma URL: https://clinicaltrials.gov/ct2/show/NCT03145181
Click on the link to continue or return to ClinicalTrials.gov Home